Navigation Links
Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
Date:2/27/2013

TEL AVIV, Israel, February 27, 2013 /PRNewswire/ --

Bioassociate has initiated coverage on KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO).  The Initiation Report contains a detailed discussion of KaloBios' business operations, market dynamics, macroeconomic data and indicators, financial results, potential cash flows, and risks.  The Initiation Report is available at: http://www.bioassociate.com/research-and-publications/publications/.

Dr. Ofir Levi , Bioassociate's CEO: "KaloBios is developing monoclonal antibody (mAb) therapeutics based on the company's proprietary Humaneered™ antibody technology platform, with focus on respiratory related indications. KaloBios' lead program, KB001-A has been licensed by Sanofi Pasteur in 2010 for the treatment of Pseudomonas aeruginosa-related hospital-acquired infections.  The total deal value of this licensing agreement is $290 million plus royalties, including a $35 million upfront payment.  KaloBios recently completed an initial public offering and is now trading on the Nasdaq Global Market.  

 We see great potential in KaloBios' technology platform and clinical development programs. Further clinical development advancements are likely to attract additional potential collaborators, which will increase investors' attention.  For these reasons we, at Bioassociate, decided to initiate analysis coverage with a target price of $10.1 per share, which reflects an upside of 47% over the current share price.

About Bioassociate

Bioassociate is an independent investment research firm specialized in the life-science sector.  Bioassociate helps inform readers about small-mid cap life science companies without extensive analyst coverage.  Bioassociate structures its teams with multidisciplinary members to conduct specific assignments.  The Bioassociate team has industry experience as well as consulting and research track record, providing investors with in-depth scientific insights and their financial manifestation.

Disclosure: 

The research report described in this press release is not constructed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer would be illegal.  Bioassociate is not soliciting any action based upon this material.  It does not take into account the particular investment objectives, financial situation, risk profile or other needs of individual investors.  Before acting on any advice or recommendation in this material, an investor should consider whether it is suitable for his/her particular circumstances and, if necessary, seek professional advice.  The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should be relied upon as such.  Opinions expressed are Bioassociate's current opinions as of the date appearing on this material only; such opinions are subject to change without notice.  

Please read each report's full disclosures and analyst background on Bioassociate website, http://www.bioassociate.com, before investing.  Bioassociate is not a registered investment adviser or broker-dealer.

The research report described in this press release contains forward-looking data subject to risks and uncertainties that could cause actual results to differ materially from those projected.  These forward-looking data represent Bioassociate's judgment as of the date of this release.  Bioassociate disclaims, however, any intent or obligation to update this forward-looking data.

Contact:
info@bioassociae.com 
+972-3-541-5050


'/>"/>
SOURCE Bioassociate
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 2017   Spectrum Pharmacy Products , a division ... exhibiting at the Educational Conference, February 22-25, 2017, in ... Coronado Bay Resort. Spectrum will be showcasing its new ... . The annual Educational Conference is presented by the ... Compounding Pharmacists (IACP) and the American College of Veterinary ...
(Date:2/20/2017)... 20, 2017  This report analyzes the worldwide markets for ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ... Rest of World. Read the full ... forecasts are provided for the period 2015 through 2022. ...
(Date:2/20/2017)... , Feb. 20, 2017  National Decision Support ... integrate the company,s CareSelect Imaging platform within the ... agreement sets the technical foundation for MEDITECH sites, ... CareSelect Imaging Clinical Decision Support Mechanism through the ... directly with and support the integration of NDSC,s ...
Breaking Medicine Technology:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... technology, welcomes you to stop by for a visit this week at HIMSS ... clinicians and executives from around the globe. Sensogram will be featured in the ...
(Date:2/20/2017)... ... 2017 , ... Chuck E. Cheese’s® and Center for Autism and Related Disorders ... E. Cheese’s locations throughout New England, New York and New Jersey to provide children ... fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. , After a ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 ... ProBrand Glitch users can easily reveal any logo with a glitch reveal in just a ... control over the style and animation of each preset. Use these presets to add a ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its ... products. Ken was impressed with the safety and reliability of the Stannah Stairlift ... his show. This endorsement by Ken Matthews can be heard on News Radio ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
Breaking Medicine News(10 mins):